40
Participants
Start Date
June 30, 2009
Primary Completion Date
November 30, 2010
Study Completion Date
October 31, 2012
Intrepide Trapidil eluting stent
"The INTREPIDE coronary stent system consists of a balloon expandable stent coated with two layers of Trapidil and parylene. The Trapidil eluting stent is pre-mounted on a Nimbus PCTA balloon and is intended for use in the treatment of CAD.~The controlled release of Trapidil is achieved through the parylene barrier, locally delivering the drug to the target lesion, inhibiting smooth muscle cell proliferation and hence neointimal hyperplasia."
Taxus drug eluting stent
Paclitaxel Drug eluting stent manufactured by Boston Scientific
RECRUITING
University Hospital Modena, Modena
Lead Sponsor
Clearstream Technologies Ltd.
INDUSTRY